Raymond E. Gibson

2.4k total citations
71 papers, 1.7k citations indexed

About

Raymond E. Gibson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Raymond E. Gibson has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Raymond E. Gibson's work include Receptor Mechanisms and Signaling (26 papers), Neuroscience and Neuropharmacology Research (13 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Raymond E. Gibson is often cited by papers focused on Receptor Mechanisms and Signaling (26 papers), Neuroscience and Neuropharmacology Research (13 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Raymond E. Gibson collaborates with scholars based in United States, Germany and China. Raymond E. Gibson's co-authors include Richard C. Reba, Shil Patel, Waclaw J. Rzeszotarski, Elaine M. Jagoda, William C. Eckelman, R. D. O’Brien, Terence G. Hamill, H. Donald Burns, Barbara Francis and B. R. Baker and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Raymond E. Gibson

71 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond E. Gibson United States 26 886 559 453 146 145 71 1.7k
Elaine M. Jagoda United States 29 794 0.9× 495 0.9× 1.2k 2.7× 151 1.0× 117 0.8× 102 2.4k
H. Donald Burns United States 23 497 0.6× 554 1.0× 402 0.9× 102 0.7× 125 0.9× 58 1.3k
Francesca Magnani Italy 20 1.6k 1.8× 734 1.3× 347 0.8× 90 0.6× 72 0.5× 34 2.3k
David R. Elmaleh United States 29 558 0.6× 647 1.2× 891 2.0× 142 1.0× 193 1.3× 120 2.7k
Stephen J. Briddon United Kingdom 32 1.9k 2.2× 901 1.6× 274 0.6× 145 1.0× 75 0.5× 87 2.6k
M. Mazière France 28 817 0.9× 1.4k 2.5× 1.0k 2.3× 148 1.0× 106 0.7× 88 2.8k
Shintaro Nishimura Japan 23 599 0.7× 210 0.4× 321 0.7× 160 1.1× 82 0.6× 76 1.5k
Terence G. Hamill United States 21 616 0.7× 421 0.8× 268 0.6× 198 1.4× 117 0.8× 50 1.4k
Tomonori Kobayashi Japan 26 1.1k 1.3× 642 1.1× 106 0.2× 368 2.5× 174 1.2× 77 2.8k
Waclaw J. Rzeszotarski United States 21 541 0.6× 290 0.5× 242 0.5× 185 1.3× 89 0.6× 46 980

Countries citing papers authored by Raymond E. Gibson

Since Specialization
Citations

This map shows the geographic impact of Raymond E. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond E. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond E. Gibson more than expected).

Fields of papers citing papers by Raymond E. Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond E. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond E. Gibson. The network helps show where Raymond E. Gibson may publish in the future.

Co-authorship network of co-authors of Raymond E. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond E. Gibson. A scholar is included among the top collaborators of Raymond E. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond E. Gibson. Raymond E. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Efferson, Clay L., Christopher T. Winkelmann, Christopher Ware, et al.. (2010). Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model. Cancer Research. 70(6). 2476–2484. 76 indexed citations
2.
Li, Yan, et al.. (2009). How can we improve antibody-based cancer therapy?. mAbs. 1(1). 67–70. 11 indexed citations
3.
Patel, Shil & Raymond E. Gibson. (2008). In vivo site-directed radiotracers: a mini-review. Nuclear Medicine and Biology. 35(8). 805–815. 81 indexed citations
4.
Hamill, Terence G., Stephen M. Krause, Christine Ryan, et al.. (2005). Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse. 56(4). 205–216. 124 indexed citations
5.
Patel, Shil, Stacey O’Malley, Brett Connolly, et al.. (2005). In vitro characterization of a γ‐secretase radiotracer in mammalian brain. Journal of Neurochemistry. 96(1). 171–178. 6 indexed citations
6.
Dallas-Yang, Qing, Xiaolan Shen, Mathias Z. Strowski, et al.. (2004). Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists. European Journal of Pharmacology. 501(1-3). 225–234. 31 indexed citations
7.
Hess, J. Fred, Richard W. Ransom, Zhizhen Zeng, et al.. (2004). Generation and Characterization of a Human Bradykinin Receptor B1 Transgenic Rat as a Pharmacodynamic Model. Journal of Pharmacology and Experimental Therapeutics. 310(2). 488–497. 19 indexed citations
8.
Lobell, Robert B., Joseph P. Davide, Nancy E. Kohl, et al.. (2003). A Cell-Based Radioligand Binding Assay for Farnesyl: Protein Transferase Inhibitors. SLAS DISCOVERY. 8(4). 430–438. 1 indexed citations
9.
O’Malley, Stacey, Tsing B. Chen, Barbara Francis, et al.. (1998). Characterization of specific binding of L-762,459, a selective α1A-adrenoceptor radioligand to rat and human tissues. European Journal of Pharmacology. 348(2-3). 287–295. 23 indexed citations
10.
Gibson, Raymond E., et al.. (1995). Characterization of the binding of [125I]L-735,286: A new nonpeptide angiotensin II AT1 receptor radioligand. Life Sciences. 56(8). 629–635. 6 indexed citations
11.
Kivlighn, Salah D., Gloria J. Zingaro, Robert A. Gabel, et al.. (1995). In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for angiotensin AT2 receptors. European Journal of Pharmacology. 294(2-3). 439–450. 3 indexed citations
12.
Gibson, Raymond E., et al.. (1994). Muscarinic receptor selectivities of 3-quinuclidinyl 8-xanthenecarboxylate (QNX) in rat brain. Life Sciences. 54(23). 1757–1765. 3 indexed citations
13.
Francis, Barbara, et al.. (1993). Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis. Thrombosis Research. 71(4). 317–324. 21 indexed citations
14.
Hanson, Robert N., et al.. (1993). Synthesis, receptor binding and tissue distribution of 17α-E[125I]iodovinyl-11β-ethyl-estradiol. Nuclear Medicine and Biology. 20(3). 351–358. 10 indexed citations
15.
Gibson, Raymond E., et al.. (1992). Synthesis and receptor affinities of new 3‐quinuclidinyl α‐heteroaryl‐α‐aryl‐α‐hydroxyacetates. Journal of Pharmaceutical Sciences. 81(4). 326–329. 3 indexed citations
16.
Gibson, Raymond E., et al.. (1992). The in vitro dissociation kinetics of (R,R)-[125I]4IQNB is reflected in the in vivo washout of the radioligand from rat brain. Life Sciences. 50(9). 629–637. 14 indexed citations
17.
Gibson, Raymond E., et al.. (1988). An autoradiographic study of muscarinic cholinoceptors in blood vessels: no localization on vascular endothelium. European Journal of Pharmacology. 153(2-3). 271–283. 24 indexed citations
18.
Zeebèrg, Barry R., Raymond E. Gibson, & Richard C. Reba. (1988). Accuracy of in vivo neuroreceptor quantification by PET and review of steady-state, transient, double injection, and equilibrium models. IEEE Transactions on Medical Imaging. 7(3). 203–212. 14 indexed citations
19.
Gibson, Raymond E., Douglas Weckstein, Elaine M. Jagoda, et al.. (1984). The characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro.. PubMed. 25(2). 214–22. 47 indexed citations
20.
Eckelman, W.C., Richard C. Reba, Raymond E. Gibson, et al.. (1979). Receptor-binding radiotracers: a class of potential radiopharmaceuticals.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(4). 350–7. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine M. Jagoda Breakdown of academic impact, for papers by H. Donald Burns Breakdown of academic impact, for papers by Francesca Magnani Breakdown of academic impact, for papers by David R. Elmaleh Breakdown of academic impact, for papers by Stephen J. Briddon Breakdown of academic impact, for papers by M. Mazière Breakdown of academic impact, for papers by Shintaro Nishimura Breakdown of academic impact, for papers by Terence G. Hamill Breakdown of academic impact, for papers by Tomonori Kobayashi Breakdown of academic impact, for papers by Waclaw J. Rzeszotarski
Rankless by CCL
2026